questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Utilisations thérapeutiques
Agents hématologiques
Coagulants
Hémostatiques
Hémostatiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Troubles de la coagulation
Tests de coagulation
Tests de coagulation
Hémostatiques
Saignement post-opératoire
Chirurgie
Antécédents médicaux
Anticoagulants
Symptômes
5
Hémorragie interne
Douleur abdominale
Troubles de la coagulation
Saignement
Réaction allergique
Hémostatiques
Prévention
5
Prévention des saignements
Interventions chirurgicales
Anticoagulants
Hygiène dentaire
Anticoagulants
Surveillance médicale
Hémophilie
Prévention des blessures
Éducation des patients
Hémostatiques
Traitements
5
Acide tranexamique
Vitamine K
Administration de médicaments
Hémostatiques
Saignement post-opératoire
Hémostatiques
Agents hémostatiques
Chirurgie
Effets secondaires
Hémostatiques
Complications
5
Réaction allergique
Antihistaminiques
Prévention des complications
Suivi médical
Signes d'alerte
Complications
Facteurs de risque
5
Facteurs de risque
Anticoagulants
Âge
Troubles de la coagulation
Médicaments
Anticoagulants
Maladies hépatiques
Coagulation
Comportements à risque
Alcool
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hémostatiques : Questions médicales les plus fréquentes",
"headline": "Hémostatiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hémostatiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-08",
"dateModified": "2025-04-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hémostatiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Coagulants",
"url": "https://questionsmedicales.fr/mesh/D003029",
"about": {
"@type": "MedicalCondition",
"name": "Coagulants",
"code": {
"@type": "MedicalCode",
"code": "D003029",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.502.270"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Agents d'inversion des anticoagulants",
"alternateName": "Anticoagulant Reversal Agents",
"url": "https://questionsmedicales.fr/mesh/D000089964",
"about": {
"@type": "MedicalCondition",
"name": "Agents d'inversion des anticoagulants",
"code": {
"@type": "MedicalCode",
"code": "D000089964",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.502.270.463.046"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antifibrinolytiques",
"alternateName": "Antifibrinolytic Agents",
"url": "https://questionsmedicales.fr/mesh/D000933",
"about": {
"@type": "MedicalCondition",
"name": "Antifibrinolytiques",
"code": {
"@type": "MedicalCode",
"code": "D000933",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.502.270.463.091"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hémostatiques",
"alternateName": "Hemostatics",
"code": {
"@type": "MedicalCode",
"code": "D006490",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Patricia Davenport",
"url": "https://questionsmedicales.fr/author/Patricia%20Davenport",
"affiliation": {
"@type": "Organization",
"name": "Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States."
}
},
{
"@type": "Person",
"name": "Martha Sola-Visner",
"url": "https://questionsmedicales.fr/author/Martha%20Sola-Visner",
"affiliation": {
"@type": "Organization",
"name": "Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States."
}
},
{
"@type": "Person",
"name": "Reihaneh Haghniaz",
"url": "https://questionsmedicales.fr/author/Reihaneh%20Haghniaz",
"affiliation": {
"@type": "Organization",
"name": "Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States."
}
},
{
"@type": "Person",
"name": "Ali Khademhosseini",
"url": "https://questionsmedicales.fr/author/Ali%20Khademhosseini",
"affiliation": {
"@type": "Organization",
"name": "Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States."
}
},
{
"@type": "Person",
"name": "A B Zemlyanoy",
"url": "https://questionsmedicales.fr/author/A%20B%20Zemlyanoy",
"affiliation": {
"@type": "Organization",
"name": "Pirogov National Medical and Surgical Center of Ministry of Health of Russia, Moscow, Russia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Relation of a Maximal Exercise Test to Change in Exercise Tolerance During Cardiac Rehabilitation.",
"datePublished": "2022-05-13",
"url": "https://questionsmedicales.fr/article/35570164",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.amjcard.2022.04.009"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nutritional State and COPD: Effects on Dyspnoea and Exercise Tolerance.",
"datePublished": "2023-04-06",
"url": "https://questionsmedicales.fr/article/37049625",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/nu15071786"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of Interrepetition Rest on Muscle Blood Flow and Exercise Tolerance during Resistance Exercise.",
"datePublished": "2022-06-18",
"url": "https://questionsmedicales.fr/article/35744085",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/medicina58060822"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sternocleidomastoid Muscle Thickness Correlates with Exercise Tolerance in Patients with COPD.",
"datePublished": "2022-11-22",
"url": "https://questionsmedicales.fr/article/36412608",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000527100"
}
},
{
"@type": "ScholarlyArticle",
"name": "Variability in exercise tolerance and physiological responses to exercise prescribed relative to physiological thresholds and to maximum oxygen uptake.",
"datePublished": "2023-01-29",
"url": "https://questionsmedicales.fr/article/36710454",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1113/EP090878"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Utilisations thérapeutiques",
"item": "https://questionsmedicales.fr/mesh/D045506"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agents hématologiques",
"item": "https://questionsmedicales.fr/mesh/D006401"
},
{
"@type": "ListItem",
"position": 6,
"name": "Coagulants",
"item": "https://questionsmedicales.fr/mesh/D003029"
},
{
"@type": "ListItem",
"position": 7,
"name": "Hémostatiques",
"item": "https://questionsmedicales.fr/mesh/D006490"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hémostatiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hémostatiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hémostatiques",
"description": "Comment diagnostiquer un trouble de la coagulation ?\nQuels signes indiquent un besoin d'hémostatiques ?\nQuels tests pour évaluer l'efficacité des hémostatiques ?\nComment évaluer un saignement post-opératoire ?\nQuels antécédents médicaux sont pertinents ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Exercise+Tolerance#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hémostatiques",
"description": "Quels sont les symptômes d'un saignement excessif ?\nComment reconnaître une hémorragie interne ?\nQuels signes d'alerte pour les troubles de la coagulation ?\nQuels symptômes d'une réaction aux hémostatiques ?\nComment identifier une thrombose ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Exercise+Tolerance#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hémostatiques",
"description": "Comment prévenir les saignements chez les patients à risque ?\nQuels conseils pour éviter les saignements ?\nComment surveiller les patients sous anticoagulants ?\nQuelles mesures pour les patients hémophiles ?\nComment éduquer les patients sur les hémostatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Exercise+Tolerance#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hémostatiques",
"description": "Quels sont les principaux hémostatiques utilisés ?\nComment administrer des hémostatiques ?\nQuels traitements pour les saignements post-opératoires ?\nQuand utiliser des agents hémostatiques locaux ?\nQuels sont les effets secondaires des hémostatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Exercise+Tolerance#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hémostatiques",
"description": "Quelles complications peuvent survenir avec les hémostatiques ?\nComment gérer une réaction allergique aux hémostatiques ?\nQuels risques de thrombose avec des hémostatiques ?\nComment prévenir les complications liées aux hémostatiques ?\nQuels signes d'alerte pour des complications ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Exercise+Tolerance#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hémostatiques",
"description": "Quels facteurs augmentent le risque de saignement ?\nComment l'âge influence-t-il le risque de saignement ?\nQuels médicaments augmentent le risque de saignement ?\nComment les maladies hépatiques affectent-elles la coagulation ?\nQuels comportements augmentent le risque de saignement ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Exercise+Tolerance#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un trouble de la coagulation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins comme le temps de prothrombine et le temps de saignement sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un besoin d'hémostatiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements excessifs, des ecchymoses fréquentes ou des saignements prolongés peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'efficacité des hémostatiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des tests comme le temps de thrombine et le temps de céphaline activé."
}
},
{
"@type": "Question",
"name": "Comment évaluer un saignement post-opératoire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "On examine la quantité de sang perdu et la durée du saignement après la chirurgie."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux sont pertinents ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de troubles de la coagulation ou d'utilisation d'anticoagulants sont importants."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un saignement excessif ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des ecchymoses, des saignements de nez fréquents et des gencives qui saignent."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hémorragie interne ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales, des vertiges ou une pâleur peuvent indiquer une hémorragie interne."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte pour les troubles de la coagulation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements prolongés après une coupure ou des saignements inhabituels sont des signes d'alerte."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une réaction aux hémostatiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, des démangeaisons ou des difficultés respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment identifier une thrombose ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un gonflement, une douleur ou une rougeur dans une jambe peuvent indiquer une thrombose."
}
},
{
"@type": "Question",
"name": "Comment prévenir les saignements chez les patients à risque ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "On peut prescrire des hémostatiques préventifs avant des interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Quels conseils pour éviter les saignements ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les anticoagulants non prescrits et maintenir une bonne hygiène dentaire."
}
},
{
"@type": "Question",
"name": "Comment surveiller les patients sous anticoagulants ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des contrôles réguliers de la coagulation sanguine sont nécessaires pour ajuster le traitement."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour les patients hémophiles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients hémophiles doivent éviter les sports de contact et suivre un traitement préventif."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les hémostatiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer sur l'utilisation correcte, les effets secondaires et l'importance du suivi médical."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux hémostatiques utilisés ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les hémostatiques courants incluent l'acide tranexamique et la vitamine K."
}
},
{
"@type": "Question",
"name": "Comment administrer des hémostatiques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être administrés par voie orale, intraveineuse ou topique selon le type."
}
},
{
"@type": "Question",
"name": "Quels traitements pour les saignements post-opératoires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "On peut utiliser des compresses, des sutures ou des hémostatiques pour contrôler le saignement."
}
},
{
"@type": "Question",
"name": "Quand utiliser des agents hémostatiques locaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés lors de chirurgies pour contrôler les saignements au site opératoire."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des hémostatiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des réactions allergiques, des nausées ou des thromboses."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les hémostatiques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des thromboses, des réactions allergiques ou des troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Comment gérer une réaction allergique aux hémostatiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il faut arrêter le traitement et administrer des antihistaminiques ou des corticostéroïdes si nécessaire."
}
},
{
"@type": "Question",
"name": "Quels risques de thrombose avec des hémostatiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation excessive d'hémostatiques peut augmenter le risque de thrombose veineuse profonde."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux hémostatiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un ajustement des doses peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte pour des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, des essoufflements ou des gonflements doivent alerter immédiatement."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de saignement ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, l'utilisation d'anticoagulants et certaines maladies augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque de saignement ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées ont un risque accru de troubles de la coagulation et de saignements."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque de saignement ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants, les anti-inflammatoires non stéroïdiens et certains antibiotiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Comment les maladies hépatiques affectent-elles la coagulation ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies hépatiques peuvent altérer la production de facteurs de coagulation, augmentant le risque de saignement."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque de saignement ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "La consommation excessive d'alcool et le tabagisme peuvent augmenter le risque de saignement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States.
Publications dans "Hémostatiques" :
2 publications dans cette catégorie
Affiliations :
Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States.
Publications dans "Hémostatiques" :
2 publications dans cette catégorie
Affiliations :
Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States.
Publications dans "Hémostatiques" :
2 publications dans cette catégorie
Affiliations :
Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Pirogov National Medical and Surgical Center of Ministry of Health of Russia, Moscow, Russia.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan. nnhk110184@kpe.biglobe.ne.jp.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
96702State Key Laboratory of NBC Protection for Civilian, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
96702State Key Laboratory of NBC Protection for Civilian, Beijing, PR China.
Publications dans "Hémostatiques" :
The purpose of this study was to test the hypothesis that an individualized exercise training target heart rate (HR) based on a maximal graded exercise test (GXT) is associated with greater improvemen...
Chronic Obstructive Pulmonary Disease (COPD) is a disease that is spreading worldwide and is responsible for a huge number of deaths annually. It is characterized by progressive and often irreversible...
Background and Objectives: Muscle blood flow is impeded during resistance exercise contractions, but immediately increases during recovery. The purpose of this study was to determine the impact of bri...
Patients with chronic obstructive pulmonary disease (COPD) have difficulties inhaling as the diaphragm becomes flattened and weakened due to lung hyperinflation. This weakened respiratory function is ...
This study aimed to evaluate the difference in the SCM thickening fraction (SCM TF) of each respiratory phase (end-expiration, resting inspiration, and end-inspiration), as measured using ultrasonogra...
Patients with COPD (n = 44) and age-matched controls (n = 20) underwent US for determination of the SCM TF. Ventilation parameters, including the peak oxygen uptake (peak VO2) and the change in the in...
The SCM was significantly thinner in patients with COPD than in controls at end-expiration. The increase in the SCM TF from end-expiration to end-inspiration in patients with COPD did not differ signi...
The SCM may be thinner in patients with COPD than in controls. The SCM TF may also be associated with exercise tolerance....
What is the central question of this study? Does prescribing exercise intensity using physiological thresholds create a more homogeneous exercise stimulus than using traditional intensity anchors? Wha...
The objective of this study was to determine whether the variability in exercise tolerance and physiological responses is lower when exercise is prescribed relative to physiological thresholds (THR) c...
Patients with multiple sclerosis (MS) experience reduced exercise tolerance that substantially reduces quality of life. The mechanisms underpinning exercise intolerance in MS are not fully clear. This...
Twenty-three patients with MS (13 women) and 20 age-matched and sex-matched healthy controls (13 women) performed a cardiopulmonary exercise test. Muscle fibre type composition, size, succinate dehydr...
Patients with MS had lower maximal oxygen uptake compared with healthy controls (V̇O...
Skeletal muscle oxidative phenotype (mitochondrial complex I and II content, SDH activity) is lower in patients with MS, contributing to reduced exercise tolerance. However, skeletal muscle mitochondr...
Following ST-segment elevation myocardial infarction (STEMI), patients with cardiac dysfunction have limitations in performing physical activity. Right ventricular (RV) function is a determinant in im...
To evaluate the association of RV function with exercise tolerance after a CR program in patients with STEMI....
Retrospective cohort study in patients with STEMI from January to December 2019. They underwent an echocardiographic assessment of RV function before a 16-session CR program. A cardiopulmonary exercis...
A total of 109 patients were included. Of all, 3.7% had global RV dysfunction, 10.1% had radial RV dysfunction, and 11% had longitudinal RV dysfunction. An association between radial or longitudinal R...
RV dysfunction is associated with a lower capacity to exercise; CR programs can be extended or modified in these patients....
The Buffalo Concussion Treadmill Test (BCTT) is a standard assessment of exercise tolerance utilized for exercise prescription following concussion and to inform decisions regarding return to play. On...
Prospective cohort study, pretest/posttest....
A total of 30 participants included 13 women (43.3%), age 23.4 (1.93) years, height 173.56 (10) cm, weight 77.35 (16.3) kg, and 11 (36.7%) with history of concussion. All participants completed a neur...
BCTT: Average percentage of heart rate maximum (%HRmax) = 93.97% (4.8%); average maximum rating of perceived exertion = 18.6 (1.5). Time-based performance in single-task and dual-task conditions signi...
Healthy participants demonstrated improvements across multiple domains of neurocognitive performance following the exercise tolerance testing on the BCTT. Understanding normal responses in neurocognit...
Critical torque (CT) and work done above it ( W ') are key predictors of exercise performance associated with neuromuscular fatigue. The aim of the present study was to understand the role of the meta...
Twelve subjects performed four knee extension time trials (6, 8, 10, and 12 min) using eccentric, isometric, or concentric contractions (3-s on/2-s off at 90°·s -1 or 30°·s -1 ) to modulate the metabo...
Compared with isometric exercise, total impulse (+36% ± 21%; P < 0.001), CT (+27% ± 30%; P < 0.001), and W ' (+67% ± 99%; P < 0.001) were increased during eccentric exercise, whereas total impulse (-2...
The contraction mode influenced both CT and W ', and consequently exercise tolerance, indicating that the metabolic cost of contraction played a key role....
In patients with chronic obstructive pulmonary disease (COPD), the clinical use of the minute ventilation-carbon dioxide production ([Formula: see text]...
We hypothesized that the [Formula: see text]...
Compared with the GOLD I-II group (n = 51), peak [Formula: see text]...
The OUES may be less useful in advanced COPD with exertional hypoxemia. The [Formula: see text]...